1文献来源Wolff AC,Lazar AA,Bondarenko I,et al.Randomized phase Ⅲ placebo-controlled trial of Letrozole plus oral Temsirolimus as first-line endocrine therapy in postmenopausal women with locally advanced or metastati...1文献来源Wolff AC,Lazar AA,Bondarenko I,et al.Randomized phase Ⅲ placebo-controlled trial of Letrozole plus oral Temsirolimus as first-line endocrine therapy in postmenopausal women with locally advanced or metastatic breast cancer[J].J Clin Oncol,2013,31（2）：195-202.2证据水平1a。展开更多
1文献来源
Wapnir IL, Dignam JJ, Fisher B, et al. Long- term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trims for DCIS[J]. J Natl Cancer Inst...1文献来源
Wapnir IL, Dignam JJ, Fisher B, et al. Long- term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trims for DCIS[J]. J Natl Cancer Inst,2011,103（6） ：478-488.展开更多
1文献来源
Vaidya JS, Wenz F, Bulsara M, et al. Riskadapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer： 5-year results for local control and overall survival from the TAR...1文献来源
Vaidya JS, Wenz F, Bulsara M, et al. Riskadapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer： 5-year results for local control and overall survival from the TARGIT-A randomised trial[J]. Lancet, 2014,383 （9917） ：603-613.展开更多
3背景 ·转移性乳腺癌（metastatic breast cancer，MBC）病人的一线治疗中，此前的3个Ⅲ期临床试验（E2100、AVADO和RIBBON-1）已经证实，贝伐单抗联合多种化疗药物，都可以提高患者的无进展生存率（progression-free survival，PF...3背景 ·转移性乳腺癌（metastatic breast cancer，MBC）病人的一线治疗中，此前的3个Ⅲ期临床试验（E2100、AVADO和RIBBON-1）已经证实，贝伐单抗联合多种化疗药物，都可以提高患者的无进展生存率（progression-free survival，PFS）。展开更多
1文献来源
Hughes LL, Wang M, Page DL, et al. Local excision alone without irradiation for ductal carcinoma in situ of the breast： A trial of the eastern cooperative oncology group [J]. J Clin Oneol, 2009, 27（32） ...1文献来源
Hughes LL, Wang M, Page DL, et al. Local excision alone without irradiation for ductal carcinoma in situ of the breast： A trial of the eastern cooperative oncology group [J]. J Clin Oneol, 2009, 27（32） ：5319-5324.展开更多
文摘1文献来源Wolff AC,Lazar AA,Bondarenko I,et al.Randomized phase Ⅲ placebo-controlled trial of Letrozole plus oral Temsirolimus as first-line endocrine therapy in postmenopausal women with locally advanced or metastatic breast cancer[J].J Clin Oncol,2013,31（2）：195-202.2证据水平1a。
文摘1文献来源
Wapnir IL, Dignam JJ, Fisher B, et al. Long- term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trims for DCIS[J]. J Natl Cancer Inst,2011,103（6） ：478-488.
文摘1文献来源
Vaidya JS, Wenz F, Bulsara M, et al. Riskadapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer： 5-year results for local control and overall survival from the TARGIT-A randomised trial[J]. Lancet, 2014,383 （9917） ：603-613.
文摘1文献来源
Hughes LL, Wang M, Page DL, et al. Local excision alone without irradiation for ductal carcinoma in situ of the breast： A trial of the eastern cooperative oncology group [J]. J Clin Oneol, 2009, 27（32） ：5319-5324.
